Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participants diagnosed with moderate-to-severe AD on background TCS who have had inadequate response to prior biologic or oral JAKi therapy. The purpose of this study is to measure the efficacy and safety of treatment with amlitelimab solution for subcutaneous (SC) injection compared with placebo in participants with moderate-to-severe AD aged 12 years and ol
Sponsor: Sanofi
Check if you qualify for this atopic dermatitis clinical trial in Los Angeles, CA
If you're searching for atopic dermatitis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.